FDA – Vaccines and Related Biological Products Advisory Committee Meeting – 9/17/2021 | FDA (U.S. Food and Drug Administration) – Video
Content Source/Owner:
U.S. Food and Drug Administration
Full day (Fri, Sep 17, 2021) virtual meeting and presentations – 8 hr 10 min
Summary:
Join us for a Vaccines and Related Biological Products Advisory Committee meeting to discuss Pfizer-BioNTech’s supplemental Biologics License Application for administration of a third dose, or “booster” dose, of the COVID-19 vaccine, Comirnaty, in individuals 16 years of age and older.
————
